Ready to start planning your care? Call us at 646-926-0945 to make an appointment.
NEJM Publishes Loxo’s Larotrectinib Clinical Data
The New England Journal of Medicine Feb. 22 published data for larotrectinib in the treatment of pediatric and adult patients whose tumors harbor tropomyosin receptor kinase gene fusions. Senior study author, MSK’s David Hyman is featured.